Lasa Supergenerics share news and announcements
NSE: LASABSE: 540702Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 19 Oct 2026. Previous close ₹5.16.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹25 Cr3,595th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Sep 2026
- −24.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Sep 2026
- −24.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day.
- 37,588
Lasa Supergenerics share news and announcements
825 announcements, routine notices left out, newest first. Page 15 of 17.
May 2018
8 May · Legal
Exchange had sought clarification from Lasa Supergenerics Limited with respect to announcement dated 27-Apr-2018, regarding " Lasa Supergenerics Limited has informed the Exchange regarding 'Intimation regarding a fire incident in Mahad MIDC very close to company s Mahad Unit.'.".On basis of above the Company is required to clarify following:1. Whether loss/damage covered by insurance or not including amount; 2. Expected quantum of loss/damage caused; The response of the Company is below: No loss to life or any injury at Lasa Unit All hard assets intact with no major impact Assets covered under appropriate insurance8 May · Legal
Reply to Clarification Sought
Apr 2018
30 Apr · Legal
Exchange has sought clarification from Lasa Supergenerics Limited with respect to announcement dated 27-Apr-2018, regarding " Lasa Supergenerics Limited has informed the Exchange regarding 'Intimation regarding a fire incident in Mahad MIDC very close to company's Mahad Unit.'.". On basis of above the Company is required to clarify following: 1. Whether loss/damage covered by insurance or not including amount; 2. Expected quantum of loss/damage caused; The response of the Company is awaited.30 Apr · Legal
Clarification27 Apr · Intimation Regarding A Fire Incident In Mahad MIDC Very Close To Companys' Mahad Unit.
19 Apr · WHO-GMP-Certificate
17 Apr · Reclassification Under Regulation 31A SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
14 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....13 Apr · Half Yearly Certificate From Practicing Company Secretary Uder Reg 40(9) Of SEBI (LODR) Regulations 2015.
12 Apr · Meeting
11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 011 Apr · Compliance Certificate For The Period Ended March 31, 2018
7 Apr · Board meeting
7 Apr · Board meeting
1 Apr · Business
Mar 2018
9 Mar · Announcement under Regulation 30 (LODR)-Updates
8 Mar · Announcement under Regulation 30 (LODR)-Updates
7 Mar · Board meeting
7 Mar · Board meeting
Feb 2018
21 Feb · Board meeting
21 Feb · Board meeting
19 Feb · Board meeting
19 Feb · Meeting Of The Board Of Director Of The Company Is Scheduled To Be Held On Wednesday February 21, 2018 At 12.00 Noon
17 Feb · Announcement under Regulation 30 (LODR)-Updates
17 Feb · Updates
14 Feb · Legal
Exchange has sought clarification from Lasa Supergenerics Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Reconciliation of profit and loss not submitted. The response of the Company is awaited.